BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 33098412)

  • 1. Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019.
    Basile K; McPhie K; Carter I; Alderson S; Rahman H; Donovan L; Kumar S; Tran T; Ko D; Sivaruban T; Ngo C; Toi C; O'Sullivan MV; Sintchenko V; Chen SC; Maddocks S; Dwyer DE; Kok J
    Clin Infect Dis; 2021 Nov; 73(9):e2952-e2959. PubMed ID: 33098412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.
    Bullard J; Dust K; Funk D; Strong JE; Alexander D; Garnett L; Boodman C; Bello A; Hedley A; Schiffman Z; Doan K; Bastien N; Li Y; Van Caeseele PG; Poliquin G
    Clin Infect Dis; 2020 Dec; 71(10):2663-2666. PubMed ID: 32442256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.
    Murata T; Sakurai A; Suzuki M; Komoto S; Ide T; Ishihara T; Doi Y
    mSphere; 2021 May; 6(3):. PubMed ID: 34011679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.
    Folgueira MD; Luczkowiak J; Lasala F; Pérez-Rivilla A; Delgado R
    Clin Microbiol Infect; 2021 Jun; 27(6):886-891. PubMed ID: 33631334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value.
    Sonnleitner ST; Dorighi J; Jansen B; Schönegger C; Gietl S; Koblmüller S; Sturmbauer C; Posch W; Walder G
    Virol J; 2021 Apr; 18(1):71. PubMed ID: 33827618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells.
    Yamada S; Fukushi S; Kinoshita H; Ohnishi M; Suzuki T; Fujimoto T; Saijo M; Maeda K;
    BMJ Open Respir Res; 2021 Feb; 8(1):. PubMed ID: 33627333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19).
    Kim DY; Lin MY; Jennings C; Li H; Jung JH; Moore NM; Ghinai I; Black SR; Zaccaro DJ; Brofman J; Hayden MK;
    Clin Infect Dis; 2023 Feb; 76(3):e416-e425. PubMed ID: 35607802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral culture and immunofluorescence for the detection of SARS-CoV-2 infectivity in RT-PCR positive respiratory samples.
    Berengua C; López M; Esteban M; Marín P; Ramos P; Cuerpo MD; Gich I; Navarro F; Miró E; Rabella N
    J Clin Virol; 2022 Jul; 152():105167. PubMed ID: 35523105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extent of infectious SARS-CoV-2 shedding in an Argentinean cohort.
    Blanco S; Aguilar JJ; Konigheim BS; Diaz LA; Spinsanti L; Beranek M; Collino C; ; Diaz M; Barbás MG; Gallego SV
    J Public Health (Oxf); 2021 Sep; 43(3):e482-e486. PubMed ID: 33963399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated
    Chan JF; Yip CC; To KK; Tang TH; Wong SC; Leung KH; Fung AY; Ng AC; Zou Z; Tsoi HW; Choi GK; Tam AR; Cheng VC; Chan KH; Tsang OT; Yuen KY
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32132196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms.
    Li X; Chan JF; Li KK; Tso EY; Yip CC; Sridhar S; Chung TW; Chiu KH; Hung DL; Wu AK; Chau SK; Liu R; Lung KC; Tam AR; Cheng VC; To KK; Chan KH; Hung IF; Yuen KY
    Infection; 2021 Apr; 49(2):257-265. PubMed ID: 32944840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among PCR-positive air samples from hospital rooms and community isolation facilities.
    Ong SWX; Tan YK; Coleman KK; Tan BH; Leo YS; Wang DL; Ng CG; Ng OT; Wong MSY; Marimuthu K
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1327-1332. PubMed ID: 33487210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit.
    Colaneri M; Seminari E; Novati S; Asperges E; Biscarini S; Piralla A; Percivalle E; Cassaniti I; Baldanti F; Bruno R; Mondelli MU;
    Clin Microbiol Infect; 2020 Aug; 26(8):1094.e1-1094.e5. PubMed ID: 32450255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?
    Rhee C; Kanjilal S; Baker M; Klompas M
    Clin Infect Dis; 2021 Apr; 72(8):1467-1474. PubMed ID: 33029620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.
    Phuphuakrat A; Pasomsub E; Srichatrapimuk S; Kirdlarp S; Suksatu A; Srisaowakarn C; Manopwisedjaroen S; Ludowyke N; Purwono PB; Priengprom T; Wongsa A; Thakkinstian A; Hongeng S; Malathum K; Thitithanyanont A; Tassaneetrithep B
    Microbiol Spectr; 2022 Jun; 10(3):e0050322. PubMed ID: 35604133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of SARS-CoV-2 from COVID-19 Patients and an Asymptomatic Individual.
    Hishiki T; Usui K; An T; Suzuki R; Sakuragi JI; Tanaka Y; Matsuki Y; Kawai J; Kogo Y; Hayashizaki Y; Takasaki T
    Jpn J Infect Dis; 2022 May; 75(3):277-280. PubMed ID: 34719530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.
    Ford L; Lee C; Pray IW; Cole D; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie DW; Cherney B; Kirby MK; Fajardo GC; Caudill M; Langolf K; Kahrs J; Zochert T; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker PL; Bonenfant G; Zhou B; Folster JM; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard RP; Killerby ME;
    Clin Infect Dis; 2021 Sep; 73(6):e1348-e1355. PubMed ID: 33846714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity.
    Santos Bravo M; Berengua C; Marín P; Esteban M; Rodriguez C; Del Cuerpo M; Miró E; Cuesta G; Mosquera M; Sánchez-Palomino S; Vila J; Rabella N; Marcos MÁ
    J Clin Microbiol; 2022 Jan; 60(1):e0160921. PubMed ID: 34669457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
    Madan T; Biswas B; Varghese PM; Subedi R; Pandit H; Idicula-Thomas S; Kundu I; Rooge S; Agarwal R; Tripathi DM; Kaur S; Gupta E; Gupta SK; Kishore U
    Am J Respir Cell Mol Biol; 2021 Jul; 65(1):41-53. PubMed ID: 33784482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.